The Overall Efficacy and Outcomes of Metronomic Tegafur-Uracil Chemotherapy on Locally Advanced Head and Neck Squamous Cell Carcinoma: A Real-World Cohort Experience

SIMPLE SUMMARY: In head and neck squamous cell carcinoma (HNSCC), more than 60% of patients presenting with locally advanced disease carries a high risk of recurrence and distant metastasis, with a poor prognosis (five-year overall survival (OS), <50%). Therefore, further prevention of recurrence...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeh, Tsung-Jang, Chan, Leong-Perng, Tsai, Hui-Ting, Hsu, Chin-Mu, Cho, Shih-Feng, Pan, Mei-Ren, Liu, Yi-Chang, Huang, Chih-Jen, Wu, Che-Wei, Du, Jeng-Shiun, Wang, Hui-Ching
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926982/
https://www.ncbi.nlm.nih.gov/pubmed/33672266
http://dx.doi.org/10.3390/biology10020168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926982/
https://www.ncbi.nlm.nih.gov/pubmed/33672266
http://dx.doi.org/10.3390/biology10020168

Ejemplares similares